格隆汇3月17日丨东莞农商银行(09889.HK)宣布，将于2026年3月27日(星期五)举行董事会会议，以考虑 (其中包括)批准本行及其附属公司截至2025年12月31日止年度的年度业绩及其发布，以及考虑会否派发 末期股息事宜。 ...

格隆汇3月17日丨有线宽频(01097.HK)公告，董事会将于2026年3月27日(星期五)举行会议，旨在(其中包 括)批准公司、其附属公司及其综合结构性实体截至2025年12月31日止年度经审核综合业绩公告及其发 布，以及考虑派付末期股息(如有)。 ...

Group 1 - The board of directors of China Construction Bank (00939.HK) will hold a meeting on March 27, 2026, to review and approve the annual performance for the accounting year ending December 31, 2025, and to consider dividend matters [1]

Core Viewpoint - Shanghai Pharmaceuticals (02607.HK) announced that its subsidiary, Shanghai Shenyang Pharmaceutical Co., Ltd. (referred to as "Shenyang Pharmaceutical"), has received the "Drug Supplement Application Approval Notice" from the National Medical Products Administration for its injectable Cefazolin Sodium, which has passed the consistency evaluation of quality and efficacy for generic drugs [1] Group 1 - The injectable Cefazolin Sodium has received approval from the National Medical Products Administration [1] - The approval notice includes notification numbers 2026B01286 and 2026B01287 [1] - The drug has successfully passed the consistency evaluation of quality and efficacy for generic drugs [1]

Group 1 - The company, GAC Group, announced that its board meeting will be held on March 27, 2026, to consider and approve the annual results for the year ending December 31, 2025, and to discuss the proposed final dividend distribution, if any [1]

Group 1 - Standard Chartered Group announced a share buyback of 977,000 shares at a cost of £15.1531 million on March 16, 2026 [1]

世茂服务(00873.HK)3月27日举行董事会会议批准全年业绩 世茂服务(00873.HK)：市拓成果亮眼 关联方 减值风险降低 相关事件 格隆汇3月17日丨世茂服务(00873.HK)宣布，公司将于2026年3月27日(星期五)举行董事会会议，藉以(其 中包括)批准公司及其附属公司截至2025年12月31日止年度之全年业绩及其发布，以及考虑派发末期股 息之建议(如有)。 ...

格隆汇3月17日丨工商银行(01398.HK)公告，将于2026年3月27日(星期五)举行董事会会议，以批准本行 截至2025年12月31日止财务年度的年度业绩，以及本行股息派发等事宜。 ...

Core Viewpoint - Shimao Group (00813.HK) announced that it will hold a board meeting on March 27, 2026, to consider and approve the annual performance for the year ending December 31, 2025, along with its release [1] Group 1 - The board meeting is scheduled for a Friday, indicating a strategic timing for financial disclosures [1] - The meeting will focus on the performance of the company and its subsidiaries, highlighting the importance of annual results in corporate governance [1] - The announcement reflects the company's commitment to transparency and accountability in its financial reporting [1]

格隆汇3月17日丨大成生化科技(00809.HK)公告，董事会会议将于2026年3月27日举行，藉以(其中包括) 审议及批准公司及其附属公司截至2025年12月31日止年度的全年业绩及考虑派发末期股息(如有)。 ...